Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × donafenib × Gastrointestinal × Clear all

Phase

Phase 2 16 Phase 1/2 3 Phase NA 2 Phase 3 1 Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1 Other hematologic neoplasm 1 Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 1

Interventions

Gemcitabine 194 Fluorouracil 130 Oxaliplatin 120 Capecitabine 110 pembrolizumab 101 Irinotecan 100 Leucovorin 94 Bevacizumab 89 Cisplatin 77 Radiotherapy 72 Nivolumab 71 Cetuximab 69 130-nm albumin-bound paclitaxel 69 Sorafenib 52 Albumin-Bound Paclitaxel 50 Cyclophosphamide 48 Paclitaxel 47 Carboplatin 42 Magnetic Resonance Spectroscopy 37 Docetaxel 35 Specimen Handling 34 Erlotinib Hydrochloride 32 fludarabine 31 durvalumab 31 Radiation 31 Taxes 30 Biopsy 28 atezolizumab 26 Ipilimumab 26 Folfox protocol 23

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04418401 2026-02-17

CISLD-8

Zhejiang University

Phase 1 Completed

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡